Stock Splits
By The Online Investor Staff, updated Fri., Sep. 30, 4:16 PM
| This Slide: #4 of 25 |
Slide #4. CohBar, Inc. (NASDAQ:CWBR) — 1 for 30 Reverse Split
Announced:
9/22/2022
Stock Split:
1 for 30
Record Date:
9/23/2022
Pay Date:
9/23/2022
CWBR Optionable?:
No
CohBar is a clinical stage biotechnology company utilizing the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to no treatment options. In addition, Co. has multiple preclinical programs, such as a program in acute respiratory distress syndrome as well as earlier stage discovery programs. Co.'s pipelines include: CB5138-3, which is for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases; CB4211, which is for the treatment of nonalcoholic steatohepatitis and obesity; and CB5064 Analogs, family of peptides that are agonists of the apelin receptor. 
CWBR Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the CWBR Page at The Online Investor (in a new window) »
 Free CWBR Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 92nd percentile
(ranked higher than approx. 92% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
